4-carbamoylimidazolium 5-olate has been researched along with Leukemia L5178 in 1 studies
*Leukemia L5178: An experimental lymphocytic leukemia of mice. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukui, M; Inaba, M; Sakurai, Y; Tsukagoshi, S | 1 |
1 other study(ies) available for 4-carbamoylimidazolium 5-olate and Leukemia L5178
| Article | Year |
|---|---|
New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
Topics: Adenine Phosphoribosyltransferase; Animals; Antineoplastic Agents; Cells, Cultured; Chromatography, Thin Layer; Enzyme Activation; Imidazoles; IMP Dehydrogenase; Inosine Nucleotides; Leukemia L5178; Leukemia, Experimental; Mice; Pentosyltransferases; Purines | 1982 |